Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates
Maximilian Pfau, Catherine A Cukras, Laryssa A Huryn, Wadih M Zein, Ehsan Ullah, Marisa P Boyle, Amy Turriff, Michelle A Chen, Aarti S Hinduja, Hermann Ea Siebel, Robert B Hufnagel, Brett G Jeffrey, Brian P Brooks, Maximilian Pfau, Catherine A Cukras, Laryssa A Huryn, Wadih M Zein, Ehsan Ullah, Marisa P Boyle, Amy Turriff, Michelle A Chen, Aarti S Hinduja, Hermann Ea Siebel, Robert B Hufnagel, Brett G Jeffrey, Brian P Brooks
Abstract
BACKGROUNDOutcome measures sensitive to disease progression are needed for ATP-binding cassette, sub-family A, member 4-associated (ABCA4-associated) retinopathy. We aimed to quantify ellipsoid zone (EZ) loss and photoreceptor degeneration beyond EZ-loss in ABCA4-associated retinopathy and investigate associations between photoreceptor degeneration, genotype, and age.METHODSWe analyzed 132 eyes from 66 patients (of 67 enrolled) with molecularly confirmed ABCA4-associated retinopathy from a prospective natural history study with a median [IQR] follow-up of 4.2 years [3.1, 5.1]. Longitudinal spectral-domain optical coherence tomography volume scans (37 B-scans, 30° × 15°) were segmented using a deep learning (DL) approach. For genotype-phenotype analysis, a model of ABCA4 variants was applied with the age of criterion EZ-loss (6.25 mm2) as the dependent variable.RESULTSPatients exhibited an average (square-root-transformed) EZ-loss progression rate of [95% CI] 0.09 mm/y [0.06, 0.11]. Outer nuclear layer (ONL) thinning extended beyond the area of EZ-loss. The average distance from the EZ-loss boundary to normalization of ONL thickness (to ±2 z score units) was 3.20° [2.53, 3.87]. Inner segment (IS) and outer segment (OS) thinning was less pronounced, with an average distance from the EZ-loss boundary to layer thickness normalization of 1.20° [0.91, 1.48] for the IS and 0.60° [0.49, 0.72] for the OS. An additive model of allele severity explained 52.7% of variability in the age of criterion EZ-loss.CONCLUSIONPatients with ABCA4-associated retinopathy exhibited significant alterations of photoreceptors outside of EZ-loss. DL-based analysis of photoreceptor laminae may help monitor disease progression and estimate the severity of ABCA4 variants.TRIAL REGISTRATIONClinicalTrials.gov identifier: NCT01736293.FUNDINGNational Eye Institute Intramural Research Program and German Research Foundation grant PF950/1-1.
Keywords: Genetic diseases; Ophthalmology; Retinopathy.
Figures
References
- Lewis RA, et al. Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet. 1999;64(2):422–434. doi: 10.1086/302251.
- Allikmets R, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15(3):236–246. doi: 10.1038/ng0397-236.
- Lambertus S, et al. Early-onset stargardt disease: phenotypic and genotypic characteristics. Ophthalmology. 2015;122(2):335–344. doi: 10.1016/j.ophtha.2014.08.032.
- Fakin A, et al. The effect on retinal structure and function of 15 specific ABCA4 mutations: a detailed examination of 82 hemizygous patients. Invest Ophthalmol Vis Sci. 2016;57(14):5963–5973. doi: 10.1167/iovs.16-20446.
- Lambertus S, et al. Progression of late-onset stargardt disease. Investig Ophthalmol Vis Sci. 2016;57(13):5186–5191.
- Müller PL, et al. Choroidal flow signal in late-onset stargardt disease and age-related macular degeneration: an OCT-angiography study. Invest Ophthalmol Vis Sci. 2018;59(4):AMD122–AMD131. doi: 10.1167/iovs.18-23819.
- Strauss RW, et al. Progression of Stargardt disease as determined by fundus autofluorescence over a 12-month period: ProgStar report no. 11. JAMA Ophthalmol. 2019;137(10):1134–1145. doi: 10.1001/jamaophthalmol.2019.2885.
- Müller PL, et al. Comparison of green versus blue fundus autofluorescence in ABCA4-related retinopathy. Transl Vis Sci Technol. 2018;7(5):13. doi: 10.1167/tvst.7.5.13.
- Sunness JS, et al. Abnormal visual function outside the area of atrophy defined by short-wavelength fundus autofluorescence in Stargardt disease. Invest Ophthalmol Vis Sci. 2020;61(4):36. doi: 10.1167/iovs.61.4.36.
- Cideciyan AV, et al. Predicting progression of ABCA4-associated retinal degenerations based on longitudinal measurements of the leading disease front. Investig Ophthalmol Vis Sci. 2015;56(10):5946–5955.
- Cideciyan AV, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13(5):525–534. doi: 10.1093/hmg/ddh048.
- Burke TR, et al. Quantitative fundus autofluorescence in recessive Stargardt disease. Invest Ophthalmol Vis Sci. 2014;55(5):2841–2852. doi: 10.1167/iovs.13-13624.
- Müller PL, et al. Quantitative fundus autofluorescence in ABCA4-related retinopathy -functional relevance and genotype-phenotype correlation. Am J Ophthalmol. 2021;222:340–350. doi: 10.1016/j.ajo.2020.08.042.
- Tanna P, et al. Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset Stargardt disease. Transl Vis Sci Technol. 2019;8(2):1. doi: 10.1167/tvst.8.2.1.
- Sparrow JR, et al. Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest Ophthalmol Vis Sci. 2013;54(4):2812–2820. doi: 10.1167/iovs.12-11490.
- Whitmore SS, et al. Analysis of retinal sublayer thicknesses and rates of change in ABCA4-associated Stargardt disease. Sci Rep. 2020;10(1):16576. doi: 10.1038/s41598-020-73645-5.
- Cideciyan AV, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009;18(5):931–941. doi: 10.1093/hmg/ddn421.
- Heath Jeffery RC, et al. Classifying ABCA4 mutation severity using age-dependent ultra-widefield fundus autofluorescence-derived total lesion size. Retina. 2021;41(12):2578–2588. doi: 10.1097/IAE.0000000000003227.
- Khan M, et al. Detailed phenotyping and therapeutic strategies for intronic ABCA4 variants in Stargardt disease. Mol Ther Nucleic Acids. 2020;21:412–427. doi: 10.1016/j.omtn.2020.06.007.
- Feuer WJ, et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol. 2013;131(1):110–111. doi: 10.1001/jamaophthalmol.2013.572.
- Strauss RW, et al. Progression of Stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt disease study (ProgStar report no. 9) JAMA Ophthalmol. 2017;135(11):1232–1241. doi: 10.1001/jamaophthalmol.2017.4152.
- Pfau M, et al. Light sensitivity within areas of geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2019;60(12):3992–4001. doi: 10.1167/iovs.19-27178.
- Müller PL, et al. Inferred retinal sensitivity in recessive Stargardt disease using machine learning. Sci Rep. 2021;11(1):1466. doi: 10.1038/s41598-020-80766-4.
- Müller PL, et al. Prediction of function in ABCA4-related retinopathy using ensemble machine learning. J Clin Med. 2020;9(8):2428. doi: 10.3390/jcm9082428.
- Sallo FB, et al. “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2012;53(10):6145–6152. doi: 10.1167/iovs.12-10580.
- Birch DG, et al. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol. 2013;131(9):1143–1150. doi: 10.1001/jamaophthalmol.2013.4160.
- Cai CX, et al. Quantifying the rate of ellipsoid zone loss in Stargardt disease. Am J Ophthalmol. 2018;186:1–9. doi: 10.1016/j.ajo.2017.10.032.
- Shen LL, et al. Natural history of autosomal recessive stargardt disease in untreated eyes: a systematic review and meta-analysis of study- and individual-level data. Ophthalmology. 2019;126(9):1288–1296. doi: 10.1016/j.ophtha.2019.05.015.
- Müller PL, et al. Progression of ABCA4-related retinopathy—prognostic value of demographic, functional, genetic, and imaging parameters. Retina. 2020;40(12):2343–2356. doi: 10.1097/IAE.0000000000002747.
- Lambertus S, et al. Asymmetric inter-eye progression in Stargardt disease. Invest Ophthalmol Vis Sci. 2016;57(15):6824–6830. doi: 10.1167/iovs.16-20963.
- Genead MA, et al. The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci. 2009;50(12):5867–5871. doi: 10.1167/iovs.09-3611.
- Sangermano R, et al. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res. 2018;28(1):100–110. doi: 10.1101/gr.226621.117.
- Sangermano R, et al. Photoreceptor progenitor mRNA analysis reveals exon skipping resulting from the ABCA4 c.5461-10T→C mutation in Stargardt disease. Ophthalmology. 2016;123(6):1375–1385. doi: 10.1016/j.ophtha.2016.01.053.
- Zhang N, et al. Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations. Hum Mol Genet. 2015;24(11):3220–3237. doi: 10.1093/hmg/ddv073.
- Lee W, et al. Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease. Hum Mol Genet. 2021;30(14):1293–1304. doi: 10.1093/hmg/ddab122.
- Khan M, et al. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics. Genet Med. 2020;22(7):1235–1246. doi: 10.1038/s41436-020-0787-4.
- Runhart EH, et al. Association of sex with frequent and mild ABCA4 alleles in Stargardt disease. JAMA Ophthalmol. 2020;138(10):1035–1042. doi: 10.1001/jamaophthalmol.2020.2990.
- Fujinami K, et al. A longitudinal study of Stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013;155(6):1075–1088. doi: 10.1016/j.ajo.2013.01.018.
- Machida S, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41(10):3200–3209.
- Velaga SB, et al. Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease. Graefes Arch Clin Exp Ophthalmol. 2019;257(3):549–556. doi: 10.1007/s00417-018-04229-3.
- Gill JS, et al. Cellular imaging of inherited retinal diseases using adaptive optics. Eye (Lond) 2019;33(11):1683–1698. doi: 10.1038/s41433-019-0474-3.
- Pfau M, et al. Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration. JAMA Ophthalmol. 2020;138(10):1026–1034. doi: 10.1001/jamaophthalmol.2020.2914.
- Sadigh S, et al. Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degeneration. Curr Eye Res. 2015;40(4):398–406. doi: 10.3109/02713683.2014.925934.
- Cideciyan AV, et al. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Investig Ophthalmol Vis Sci. 2005;46(12):4739–4746.
- Almohaimeed A, Einbeck J. Response Transformations for Random Effect and Variance Component Models. Accessed December 8, 2021.
- Bates D, et al. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.
Source: PubMed